Advertisement
Advertisement
BRNS
Barinthus Biotherapeutics plc - ADR
0.55
USDSponsored
+0.01
+1.26%
Mar 25, 15:59 UTC -4
Closed
Pre-Market
0.58
+0.03
+5.45%
BRNS Earnings Reports
Positive Surprise Ratio
BRNS beat 13 of 20 last estimates.
65%
Next Report
Date of Next Report
May 05, 2026
Estimate for Q1 26 (Revenue/ EPS)
--
/-$0.32
Implied change from Q4 25 (Revenue/ EPS)
--
/+18.52%
Implied change from Q1 25 (Revenue/ EPS)
--
/-34.69%
Barinthus Biotherapeutics plc - ADR earnings per share and revenue
On Mar 13, 2026, BRNS reported earnings of -0.27 USD per share (EPS) for Q4 25, beating the estimate of -0.35 USD, resulting in a 23.27% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +4.83% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 4 analysts forecast an EPS of -0.32 USD, with revenue projected to reach -- USD, implying an increase of 18.52% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Dyadic International, Inc.
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.04
Actual
-$0.06
Surprise
-30.72%
TELA Bio, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.18
Actual
-$0.16
Surprise
+14.12%
BioCardia, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.17
Actual
-$0.06
Surprise
+65.40%
Celcuity Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$1.06
Actual
-$0.97
Surprise
+8.72%
Precigen, Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.01
Surprise
+88.24%
Absci Corporation Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.23
Surprise
-16.04%
Candel Therapeutics, Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.25
Actual
-$0.54
Surprise
-115.31%
LENZ Therapeutics, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.99
Actual
-$1.15
Surprise
-17.10%
Fennec Pharmaceuticals Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
$0.03
Actual
-$0.11
Surprise
-408.12%
Equillium, Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.06
Actual
-$0.04
Surprise
+35.28%
FAQ
What were Barinthus Biotherapeutics plc - ADR's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Barinthus Biotherapeutics plc - ADR reported EPS of -$0.27, beating estimates by 23.27%, and revenue of $0.00, 0% as expectations.
How did the market react to Barinthus Biotherapeutics plc - ADR's Q4 2025 earnings?
The stock price moved up 4.83%, changed from $0.60 before the earnings release to $0.63 the day after.
When is Barinthus Biotherapeutics plc - ADR expected to report next?
The next earning report is scheduled for May 05, 2026.
What are the forecasts for Barinthus Biotherapeutics plc - ADR's next earnings report?
Based on 4
analysts, Barinthus Biotherapeutics plc - ADR is expected to report EPS of -$0.32 and revenue of -- for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement